Source:http://linkedlifedata.com/resource/pubmed/id/12870779
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2003-7-21
|
pubmed:abstractText |
To investigate the prognostic indicator, we examined the expression of alpha6- and alpha5-integrin and interleukin-1 receptor type I (IL-1RI) immunohistochemically, and analyzed the correlation between immunohistochemical findings and clinicopathological factors in pancreatic cancer. In patients with a strongly expressing alpha6-integrin subunit or weakly expressing alpha5beta1-integrin in pancreatic cancer tissues there was a significant association with advanced TNM stage (P = 0.027 and 0.014, respectively), presence of liver metastases (P = 0.032 and 0.002, respectively), and poor prognosis (P = 0.0155 and 0.0056, respectively). In patients with a weakly expressing alpha6 integrin subunit or weakly expressing alpha5beta1-integrin in noncancerous pancreatic tissues there was a significant association with poor prognosis (P = 0.0324 and 0.0396, respectively). Multivariate analysis demonstrated that strong expression of alpha6- and weak expression of alpha5beta1-integrin were found to be independent prognosticators in pancreatic cancer patients. Our present results indicate that alpha6beta1- and alpha5beta1-integrin expression can be a significant prognostic indicator in pancreatic cancer.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0163-2116
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
48
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1241-50
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12870779-Aged,
pubmed-meshheading:12870779-Carcinoma, Pancreatic Ductal,
pubmed-meshheading:12870779-Female,
pubmed-meshheading:12870779-Humans,
pubmed-meshheading:12870779-Immunohistochemistry,
pubmed-meshheading:12870779-Integrins,
pubmed-meshheading:12870779-Liver Neoplasms,
pubmed-meshheading:12870779-Male,
pubmed-meshheading:12870779-Middle Aged,
pubmed-meshheading:12870779-Neoplasm Metastasis,
pubmed-meshheading:12870779-Neoplasm Staging,
pubmed-meshheading:12870779-Pancreatic Neoplasms,
pubmed-meshheading:12870779-Prognosis,
pubmed-meshheading:12870779-Receptors, Interleukin-1,
pubmed-meshheading:12870779-Receptors, Interleukin-1 Type I
|
pubmed:year |
2003
|
pubmed:articleTitle |
Expression and prognostic roles of integrins and interleukin-1 receptor type I in patients with ductal adenocarcinoma of the pancreas.
|
pubmed:affiliation |
Department of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Sciences Nagoya, Japan.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|